3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cisplatin
1041
Cyclophosphamide
973
Carboplatin
954
Radiotherapy
893
Bevacizumab
847
Gemcitabine
817
pembrolizumab
759
Paclitaxel
738
Docetaxel
734
Oxaliplatin
706
Capecitabine
649
Fluorouracil
564
Rituximab
559
Nivolumab
506
Dexamethasone
487
Etoposide
468
Doxorubicin
458
Irinotecan
442
Drug Therapy
402
Leucovorin
377
Cytarabine
342
Cetuximab
340
Lenalidomide
326
Trastuzumab
323
Pemetrexed
315
durvalumab
295
Filgrastim
287
Magnetic Resonance Spectroscopy
278
Temozolomide
275
Prednisone
274
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER
×
AZD 8931
×
Clear all
NCT02299999
2025-01-15
SAFIR02_Breast
UNICANCER
Phase 2
Active not recruiting
1,460 enrolled
NCT02117167
2024-01-10
SAFIR02_Lung
UNICANCER
Phase 2
Completed
999 enrolled
NCT01862003
2019-08-19
PANTHER
University College, London
Phase 2
Completed
24 enrolled